CBLB and familial dilated cardiomyopathy: According to the experimental results in vitro, we speculate that Yangxinshi has a therapeutic effect on CF in DCM by regulating CBL pathway, promoting the expression of Cbl-b and inhibiting TGF- β/Smads pathway.